223 related articles for article (PubMed ID: 31526389)
1. Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats.
Tao X; Cai L; Chen L; Ge S; Deng X
J Ovarian Res; 2019 Sep; 12(1):86. PubMed ID: 31526389
[TBL] [Abstract][Full Text] [Related]
2. Expression of SIRT1 in the ovaries of rats with polycystic ovary syndrome before and after therapeutic intervention with exenatide.
Tao X; Zhang X; Ge SQ; Zhang EH; Zhang B
Int J Clin Exp Pathol; 2015; 8(7):8276-83. PubMed ID: 26339397
[TBL] [Abstract][Full Text] [Related]
3. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats.
Xing C; Lv B; Zhao H; Wang D; Li X; He B
J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
5. Regulatory effects of the AMPKα-SIRT1 molecular pathway on insulin resistance in PCOS mice: An in vitro and in vivo study.
Tao X; Chen L; Cai L; Ge S; Deng X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):615-620. PubMed ID: 28988114
[TBL] [Abstract][Full Text] [Related]
6. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
[TBL] [Abstract][Full Text] [Related]
7. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Zhang S; Tu H; Yao J; Le J; Jiang Z; Tang Q; Zhang R; Huo P; Lei X
Reprod Biol Endocrinol; 2020 Jun; 18(1):58. PubMed ID: 32493421
[TBL] [Abstract][Full Text] [Related]
8. Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment.
Zheng S; Liu E; Zhang Y; Long T; Liu X; Gong Y; Mai T; Shen H; Chen H; Lin R; Zheng Y; Xie Y; Wang F
Endocr J; 2019 Jun; 66(6):555-562. PubMed ID: 30918134
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Acupuncture on Reproductive Endocrine and p-Akt Protein Expression in Polycystic Ovary Syndrome Rats with Insulin Resistance].
Zhang Y; Cao S; Wen SD; Re ZC; Li YP; Tong L
Zhen Ci Yan Jiu; 2018 Oct; 43(10):622-6. PubMed ID: 30365256
[TBL] [Abstract][Full Text] [Related]
11. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
13. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.
Tao T; Zhang Y; Zhu YC; Fu JR; Wang YY; Cai J; Ma JY; Xu Y; Gao YN; Sun Y; Fan W; Liu W
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1420-e1432. PubMed ID: 32995892
[TBL] [Abstract][Full Text] [Related]
14. [Effects of visfatin and metformin on insulin resistance and reproductive endocrine in rats with polycystic ovary syndrome].
Zhang T; Zou X; Su S; Li T; Wan J; Gu J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1314-8. PubMed ID: 25263366
[TBL] [Abstract][Full Text] [Related]
15. Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19.
Wang Q; Shang J; Zhang Y; Zhou W
Cell Cycle; 2019 Oct; 18(19):2538-2549. PubMed ID: 31405334
[TBL] [Abstract][Full Text] [Related]
16. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
17. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
[TBL] [Abstract][Full Text] [Related]
18. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
[TBL] [Abstract][Full Text] [Related]
19. Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats.
Patel R; Shah G
Arch Med Res; 2018 Apr; 49(3):154-163. PubMed ID: 30104075
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome.
Ito-Yamaguchi A; Suganuma R; Kumagami A; Hashimoto S; Yoshida-Komiya H; Fujimori K
Gynecol Endocrinol; 2015 Jan; 31(1):44-7. PubMed ID: 25237893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
